History
 

FABAD  J. Pharm. Sci.
ISSN 1300-4182
Copyright Ó 2005 FABAD. All rights reserved 

FABAD J. Pharm. Sci., 28(3), 149-160, 2003. PDF (323 KB)

Scientific Reviews

ABSTRACT

Bioavailabillity File: TERBUTALINE

Yasemin KARABEY*, SELMA ŞAHİN*,o, Levent ÖNER*, A. Atilla HINCAL*
*Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06100 Sıhhiye, Ankara, TURKEY.
oCorresponding Author

Summary:
Terbutaline, a synthetic ?2-adrenoceptor (?2AR) stimulant, is used mainly in respiratory medicine (bronchial asthma, chronic bronchitis and emphysema) and in obstetrics. It exists as a racemic mixture (+ and – terbutaline). Although (-) terbutaline is responsible for ? agonist activity, (+) terbutaline is devoid of such pharmacological activity. Terbutaline is incompletely absorbed from the gastrointestinal tract. Its bioavailability is low (10-15%) and stereoselective. It is subject to fairly extensive first pass metabolism by sulfate conjugation in the liver and possibly in the gut wall. In this review, physicochemical and pharmacological properties, pharmacokinetics and bioavailability of terbutaline are discussed.

Keywords:
Terbutaline, Pharmacokinetics, Bioavailability, ?2-agonists, Asthma, Enantiomer